Grant Sweep

Consolidated research funding across disease areas and research fields — federal, foundation, state & industry sources in one filterable place.

← Back to opportunities
OpenClinical trial: Optional / allowed

Successor-in-Interest (Type 6 Parent Clinical Trial Optional)

National Institutes of Health (NIH) · NIH Institute/Center · PA-24-253

Source: Grants.gov · View original posting ↗

Award
Amount not listed
Deadline
Jul 17, 2027
Letter of intent
Mechanism
Duration
Expected awards
Funding cycle
Standard NIH dates
Open date
Jul 11, 2024
Total funding
Clinical trial
Optional / allowed
Small businessHigher educationNonprofitGovernmentForeign entities

Description

The National Institutes of Health (NIH) hereby notify recipient organizations holding specific types of NIH grants, listed in the full Funding Opportunity Announcement (FOA), that applications for change of recipient organization status, often referred to in this announcement as Successor-In-Interest, may be submitted to this NOFO. Applications for change of recipient organization status are considered prior approval requests (as described in Section 8.1.2.8 of the NIH Grants Policy Statement) and will be routed for consideration directly to the Grants Management Specialist named in the current award.Although successor-in-interest requests may be submitted through this NOFO, there is no guarantee that an award will be transferred to the new organization. All applicants are encouraged to discuss potential requests with the awarding IC before submission.

Data notes: award amount not published in the source feed; administering NIH institute could not be identified from the opportunity number.